Add MJ Journals: ‘Medical Cannabis and Cannabinoids’

“Medical Cannabis and Cannabinoids” is a peer-reviewed journal offering an international forum to present and discuss recent advances in the rapidly developing field of medical cannabis and cannabinoids.

JAMA op-ed: ‘Educating Physicians About MJ’

Marijuana use is prevalent both in states where it is legal to some degree and in states where it is not. However, evidence suggests that many physicians may be unprepared for this reality.

Can Medical Marijuana Help with Dementia?

There’s no official endorsement of medical cannabis for dementia, but with or without scientific data, more and more people are willing to investigate cannabis to treat their loved ones.

The International Cannabinoid Research Society (ICRS) has adopted the journal Cannabis and Cannabinoid Research (CCR)

By Fred Gardner The International Cannabinoid Research Society (ICRS) has adopted the journal Cannabis and Cannabinoid Research (CCR) as its official publication. Dr. Daniele Piomelli, a pharmacologist at UC Irvine, edits the journal.

The press release from the publisher states that CCR is “extremely excited” by the affiliation. The release does not list clinical among the types of studies the ICRS has been “spearheading,” but does list “misuse potential.”

“Beyond CBD” makes its entrance as a supplement to the peer-reviewed journal Alternative

A note from the publisher of Alternative Therapies in Health and Medicine introduces “the first issue of Beyond CBD, a special supplement.” They’re obviously planning more. The lead article, “The Endocannabinoid System and its Modulation by Cannabidiol (CBD)” by Jamie Corroon, ND, MPH, and Jake F. Felice, ND, LMP is the most thorough and well-written overview we’ve seen.

Humboldt Humbled by Legalization

Although it’s entitled “How Legalization Changed Humboldt County Marijuana,” Emily Witt’s article in the New Yorker is not about new plant varieties but about new social realities. 

You Must Remember This (Re: Mushrooms)

Eating mushrooms may reduce the risk of cognitive impairment, according to a study published in the Journal of Alzheimer’s Disease.

Epidiolex Weighs in at Schedule V

EPIDIOLEX®, a cannabidiol oral solution has been transferred to Schedule V, the lowest restriction classification, by the U.S. Drug Enforcement Administration. But CBD remains on Schedule I, due to its supposed abuse liability.

Russo’s Grand Unified Theory

Dr. Ethan Russo’s research on the Grand Unified Theory (GUT) that discusses how cannabis-based treatment and nutritional approaches can address five conditions that are difficult to treat with conventional medicine.

Meiri Publishes in Nature

In this seminal study, Dr. Dedi Meiri and his team from Israel enhance our knowledge of the content, effect, and variability of cannabinoids across 36 individual cannabis cultivars.

Our Letter to the Editor of JAMA

SCC Board Members oppose several key provisions JAMA wants the state medical boards to adopt.

Research Pioneer: Ethan Russo MD

ethan-russo2Ethan Russo, MD, is a board-certified neurologist and psychopharmacology researcher. He has held faculty appointments in Pharmaceutical Sciences at the University of Montana, in Medicine at the University of Washington, and as visiting professor, Chinese Academy of Sciences. He is currently Past-President of the International Cannabinoid Research Society, and is former Chairman of the International Association for Cannabinoid Medicines.